OsiriX

What is OsiriX?

OsiriX is a company within the Medical Software category. OsiriX is a professional medical imaging workstation designed specifically for macOS. It functions as a DICOM viewer and post-processing tool, enabling clinicians and researchers to visualize and manipulate complex 2D and 3D medical images such as CT and MRI scans. Originally developed as an open-source project, it has become a standard in the radiology community with specialized versions available for clinical diagnostics and research.

When was OsiriX founded and where is it based?

OsiriX was founded in 2004 and is headquartered in Geneva, Switzerland.

What is OsiriX's Brand Authority Index tier?

OsiriX is rated Leader on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.

How accurately do AI models describe OsiriX?

AI narrative accuracy for OsiriX is Moderate. Significant factual deltas detected. Inconsistent representation across models.

How do AI models position OsiriX competitively?

AI models classify OsiriX as a Challenger. AI names competitors first.

How visible is OsiriX in buyer-intent AI queries?

OsiriX appeared in 5 of 6 sampled buyer-intent queries (83%). OsiriX is the dominant answer for Mac-specific medical imaging queries, but it is less likely to appear in 'Best DICOM viewer' queries that do not specify an operating system, as Windows-based or web-based tools often rank higher in general searches.

What do AI models currently say about OsiriX?

AI models will consistently describe OsiriX as a premier Mac-based medical imaging tool, particularly strong in 3D visualization. However, they struggle to provide accurate, up-to-date information regarding its current licensing fees and the specific functional differences between its various modern versions. Key gap: The biggest gap is the distinction between the legacy open-source 'OsiriX' and the modern, commercialized 'OsiriX MD' and 'OsiriX Lite.' AI models often conflate these, leading to confusion about its current cost and licensing.

How many facts about OsiriX are well-documented vs need fixing vs retrieval-dependent?

Of 5 key facts verified about OsiriX, 3 are well-documented (likely accurate across AI models), 2 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.

What is OsiriX's biggest AI narrative vulnerability?

The claim regarding its open-source status is the most likely to be wrong, as the brand transitioned away from a purely open-source model years ago.

What problems does OsiriX solve for buyers?

Buyers turn to OsiriX for Physical Film & Basic DICOM Viewers: Radiologists manually viewing physical film or using basic image viewers built into hospital workstations., Status Quo Medical Imaging: Using standard image viewers or not adopting advanced 3D post-processing workflows., among 2 documented problem areas.

What questions do buyers ask AI about OsiriX?

Buyers evaluating OsiriX typically ask AI models about "best DICOM viewer for Mac", "3D reconstruction software for MRI data", "cloud-based PACS for radiology", and 3 similar queries.

Who are OsiriX's main competitors?

OsiriX's main competitors are PostDICOM. According to AI models, these are the brands most frequently named alongside OsiriX in buyer-intent queries.

What does OsiriX offer?

OsiriX's core products are OsiriX MD, OsiriX Lite, OsiriX HD (iOS).

How is OsiriX priced?

OsiriX uses Freemium (Lite version is free; MD version requires a paid license).

Who does OsiriX target?

OsiriX serves Radiologists, Medical Researchers, Surgeons, Academic Institutions.

What differentiates OsiriX from competitors?

OsiriX The only DICOM viewer optimized specifically for macOS and iOS that combines high-end 3D reconstruction with FDA clinical clearance.

Brand Authority Index (BAI) tier: Leader (exact score locked for unclaimed brands)

Archetype: Challenger

https://optimly.ai/brand/osirix

Last analyzed: April 10, 2026

Verified from OsiriX website

Founded: 2004

Headquarters: Geneva, Switzerland

Competitors

Problems this brand solves

Buyers search for